Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Ripening Approaches for Prompt Induction and Delivery: Sequential vs. Combined Cervical Ripening in First-Time Moms

Official title: Ripening Approaches for Prompt Induction and Delivery - Sequential Versus Concurrent Dilapan-S and Misoprostol to Achieve Vaginal Delivery (RAPID-DS)

Run by Ochsner Health System · NCT07717502 · Data updated 2026-11-12

This study tests whether a sequential or a combined method of cervical ripening helps first-time moms deliver vaginally within 24 hours during labor induction.

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment260 (estimated)
SponsorOchsner Health System
Academic / other
Locations1 site (New Orleans, Louisiana)
StatusRecruiting
StartedAugust 18, 2026
Main results expectedDecember 2027
Study endsDecember 2027
Registry record updatedAugust 24, 2026
Trial IDNCT07717502 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Nulliparous women with singleton, vertex pregnancies at term who are eligible for outpatient cervical ripening and meet local eligibility criteria.

Probably not a fit

Women with uterine scars, prior full-thickness procedures, placental abnormalities, or other high-risk factors may not benefit from these strategies.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The trial compares two multimodal cervical ripening strategies in nulliparous women at term undergoing induction of labor. It aims to determine which approach more effectively achieves vaginal delivery within 24 hours. Interventions involve sequential cervical ripening versus inpatient combined cervical ripening with Dilapan-S devices and misoprostol. Eligible participants are nulliparous, carrying singleton, vertex pregnancies at term who may be candidates for outpatient ripening. The study is led by Ochsner Health System with Medicem International as collaborators at Ochsner Baptist in New Orleans.

Why it matters

Potential benefit: If successful, the approach could shorten labor time and increase chances of vaginal delivery for first-time moms undergoing induction.

How similar studies have gone: Previous studies in cervical ripening have shown varying success with multimodal strategies; this trial tests a direct comparison between sequential and combined methods in a specific population.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Nulliparous patients with singleton pregnancies with vertex lie at term receiving prenatal care that are eligible for outpatient cervical ripening will be eligible

Exclusion Criteria:

* age less than 18,
* suspected major fetal anomalies (including suspected or proven chromosome anomalies, congenital cardiac disease expected to require neonatal intervention, and multiple anomalies suggestive of a complex syndrome),
* fetal growth restriction
* oligohydramnios
* prior full thickness
* uterine scar
* placenta previa,
* low-lying placenta,
* premature rupture of amniotic membranes,
* cervical dilation \> 2 cm
* modified Bishop score \> 4
* residence greater than 60 minutes from the hospital

Where it's running

  • Ochsner Baptist
    New Orleans, Louisiana, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.